Built on the clinically proven science of neuroplasticity, JOGO comprises an AI driven mobile app and wearable sensors to to treat chronic pain, stroke, incontinence, Parkinson's tremors and movement disorders associated with neurological conditions via Telemedicine.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company focused on innovative approaches to driving durable behavior change in chronic disease, to positively impact health outcomes and cost of care. Dario creates durable behavior change in chronic conditions. For individuals facing the challenges of diabetes, prediabetes, hypertension, obesity, and other chronic conditions, Dario delivers highly personalized digital interactions, actionable data, engaging digital tools and easy to use monitoring devices plus human support. Combined, these touch points make doing the "right thing the easy thing" by encouraging proactive, positive behavior changes that lead to improved health outcomes. Dario chronic condition digital therapeutics solution and the MyDario™ mobile app is loved and recommended by close to 100,000 users around the globe--with a 4.9 star rating across 11,000 reviews on the Apple App Store, and world-class Net Promoter Score (NPS) of 77.

​Studies show that over 65% of patients with chronic pain, Parkinson's Disease, post-acute stroke, and pelvic floor disorders do not fully recover with current treatments - resulting in hospital readmissions and ER visits. The JOGO digital rehabilitation solution was created over nine years of tireless research and testing. Several chronic residual disabilities can be treated via telemedicine using JOGO.